J Clin Med 2022 Feb 11;11(4). Epub 2022 Feb 11.
Department of Pediatrics and Neurology, Penn State Health Children's Hospital, Penn State College of Medicine, Hershey, PA 17033, USA.
Since the emergence of SARS-CoV-2, several studies have been published describing neuromuscular manifestations of the disease, as well as management of pre-existing pediatric neuromuscular disorders during the COVID-19 pandemic. These disorders include muscular dystrophies, myasthenic syndromes, peripheral nerve disorders, and spinal muscular atrophy. Such patients are a vulnerable population due to frequent complications such as scoliosis, cardiomyopathy, and restrictive lung disease that put them at risk of severe complications of COVID-19. Read More